2-Hydroxyglutarate in onco-pathway: a metabolic driver of proto-oncogene activation

Masthan Thamim, Debdas Dhabal, M. M. Balamurali, Krishnan Thirumoorthy · 2026

Read 2-Hydroxyglutarate in onco-pathway: a metabolic driver of proto-oncogene activation by Masthan Thamim, Debdas Dhabal, M. M. Balamurali, Krishnan Thirumoorthy (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13171342.txt.

Description

Thamim and three colleagues review a waste product of cell chemistry that can switch on cancer traits in twenty twenty-six. The compound, called 2HG, builds up when cancer cells rewire how they make energy. It comes in two mirror forms, like left and right hands. Both forms mimic a normal cell compound and block the enzymes that use it.

That block scrambles gene tags, cell repair, and growth signals, which can start and spread tumors. The two mirror forms act in unlike ways on these paths. The review pulls this picture together and weighs the compound as a marker and drug target. Blocking its effects could help some patients, they argue.

Catalog record

CREATORMasthan Thamim, Debdas Dhabal, M. M. Balamurali, Krishnan Thirumoorthy
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE82 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13171342

Browse the full library · About the Tower of Babel